DPT Vaccine Market Size ,Share, Development by 2027
There is an increase in demand of diphtheria tetanus andpertussis vaccine across the globe and rising awareness regarding prevention ofdiphtheria, tetanus, and pertussis is major factors which are responsible forthe growth of this market. The market is expected to show large opportunitiesin the coming future with the advancement of technology in developing countries and new products with increased accuracy.
The Global Diphtheria Tetanus and Pertussis Vaccine (DPT)vaccine Market Growth exponentially owing to rising prevalence of chronicdisease and increasing usage of combination vaccine and therapy are the majorfactor driving the DPT vaccine Market. Globally the market for DPTvaccine market size is expected to grow at the rate of about 7.3% CAGR from2016 to 2027.
Market Key Players:
Merck & Co., Inc (U.S), Sanofi (France), GSK (U.S),Lanzhou Institute of Biological Products (China), Wyeth (U.S), ChironPharmaceutical Pvt Ltd (India), Serum Institute of India Pvt. Ltd. (India),Lanzhou Institute of Biological Products (China) and others are some of theprominent players at the forefront of competition in the Global DPT vaccine Market and are profiled in MRFR Analysis.
Diverging product markets can be seen in preferences fortraditional vaccines such as DTP. According to WHO, developed countries preferto purchase a component of the DPT vaccines such as procure acellular pertussis(DTaP), while most developing countries purchase vaccines with whole cellpertussis (DTwP) components.
However, some of the challenges which the market is expectedto face includes competition from new entrants or big pharmaceutical giantsentering the business or market and the continuous advancements in the product.Furthermore there are some hindering factors which are restricting the marketgrowth such as side effects and complications during inhalation, high prices of devices, and lack of accuracy etc.
Global DPT vaccine Market - Regional Analysis
Globally, DPT Vaccine market consists of four regions NorthAmerica, Europe, Asia-Pacific and Middle East and Africa. North America is the largest market fordiphtheria tetanus and pertussis vaccine (DPT) vaccine.
The North American market for DPT Vaccine is expected togrow steadily over the forecasted period. This is due to the presence of highconcentration of major market players in North America and its emphasis onvaccination against DPT. North American market consists of countries like theU.S., Canada and Mexico. Death rate sue communicable disease is seen to be growing, thus highlighting the importance of immunization. For instance, In March 2015 U.S FDA approved the use of Quadracel for immunization of children from 4 to 6 years of age. This was a great achievement for Sanofi helping it to maintain its leading position in the market.
Europe is the second-largest market for DPT Vaccine which isexpected to grow at an overwhelming CAGR during the forecast period. This isdue to increasing research and development activities by pharmaceuticalcompanies and research institutes. The market is growing continuously in Europeas the key market players invested huge financial resources on research and development activities for the production of effective vaccines. Increasing awareness about immunization ofchildren against Diphtheria, tetanus and pertussis also drive this market in Europe.
Moreover, Asia Pacific is expected to be the fastest growingmarket for DPT Vaccine market. India is expected to be the emerging and fastestgrowing market. Presence of large patient pool drive this market inAsia-pacific. This region is expected to grow at a higher rate due to rapidpopulation growth, increase in adoption for vaccination, and growth in prevalence of infectious disease. Governments in developing countries of Asia-Pacific have undertaken various vaccinations programs. National Health Mission in India provide vaccination against diphtheria, pertussis, tetanus and polio.
The market shows steady growth in Middle East and Africa. InMiddle East and Africa the demand for DPT vaccine is less than other regionsacross the globe.
Global DPT vaccine Market - Company Analysis
Merck: Merck provides a wide range of vaccines whichincludes BCG USP, Pneumonix, Varivax, Pedvax HIB, Recombivax HB and others.
Sanofi: Sanofi is a global life sciences company committedto improving access to healthcare and supporting the people we serve throughoutthe continuum of care. From prevention to treatment, Sanofi transformsscientific innovation into healthcare solutions, in human vaccines, rare diseases,multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions, consumer healthcare, established prescription products and generics. Diphtheria and Tetanus Toxoids and acellular Pertussis Vaccine called Daptacel is the product offered by Sanofi which is the major market player.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers tounravel the complexity of various industries through our Cooked Research Report(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFRteam have supreme objective to provide the optimum quality market research andintelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com